These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899 [TBL] [Abstract][Full Text] [Related]
12. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR). Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889 [TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. Benson MD; Dasgupta NR; Rissing SM; Smith J; Feigenbaum H Amyloid; 2017 Dec; 24(4):219-225. PubMed ID: 28906150 [TBL] [Abstract][Full Text] [Related]
17. Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition. Saelices L; Chung K; Lee JH; Cohn W; Whitelegge JP; Benson MD; Eisenberg DS Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6741-E6750. PubMed ID: 29954863 [TBL] [Abstract][Full Text] [Related]
18. Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis. Anan I; Suhr OB; Liszewska K; Mejia Baranda J; Pilebro B; Wixner J; Ihse E PLoS One; 2022; 17(3):e0266092. PubMed ID: 35358243 [TBL] [Abstract][Full Text] [Related]
19. Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. Norgren N; Hellman U; Ericzon BG; Olsson M; Suhr OB PLoS One; 2012; 7(11):e49981. PubMed ID: 23185504 [TBL] [Abstract][Full Text] [Related]
20. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy? Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]